Curtis Baum, MD
Gastroenterology · Topeka, KSNPI 1861401390
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by AbbVie at 28.0% of the total. Reporting peaked in 2023 at $3,336 and has fallen 92.7% since, to $245 in 2025.
Across 53 payments — averaging $136.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Janssen Research & Development, LLC$2K
- Pfizer$2K
- Janssen Scientific Affairs, LLC$637
- Takeda Pharmaceuticals U.S.A., Inc.$547
- Bristol Myers Squibb$282
- plus $221 from 3 others
Across 2,556 payments — averaging $1620.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$1.6M
- AbbVie$936K
- Janssen Research & Development, LLC$924K
- Eli Lilly$201K
- Genentech, Inc.$136K
- Bristol Myers Squibb$101K
- plus $271K from 5 others
What the payments were for
- Consulting fees$3,37547%
- Travel & lodging$1,34019%
- Food & beverage$2,51235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $2,022 |
| Janssen Research & Development, LLC | 14 | $2,011 |
| Pfizer(2 entities) | 3 | $1,507 |
| Janssen Scientific Affairs, LLC | 4 | $637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $547 |
| Bristol Myers Squibb | 6 | $282 |
| Johnson & Johnson | 3 | $168 |
| Lilly USA, LLC | 1 | $28 |
| Genentech, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,227 in reported general payments places this provider in the 85th percentile of 98 gastroenterology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 178 | $12,130 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 255 | $3,359 |
| Mesalamine | 13 | $2,941 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 12 | $1,905 |
| Pantoprazole Sodium | 230 | $1,569 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 101 | $1,555 |
| Budesonide DrBudesonide | 12 | $1,355 |
| Omeprazole | 81 | $1,084 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 34 | $874 |
| Sucralfate | 28 | $676 |
| Ondansetron OdtOndansetron | 279 | $576 |
| LoperamideLoperamide Hcl | 17 | $566 |
| Esomeprazole Magnesium | 26 | $509 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $165 |
| Ondansetron Hcl | 20 | $23 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Topeka
- Balaji DattiTopeka$6K
- Shekhar ChallaTopeka$5K
- Richard TayTopeka$3K
- Khalil AbuamrTopeka$768
- Phani Ashok AttaluriOlathe$957K
- Ryan TaylorKansas City$241K
- Winston DunnKansas City$169K
- Francis DaileyLeawood$82K
- Rashmi TadiparthiKansas City$60K
- Prateek SharmaKansas City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.